These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20627670)

  • 21. Practice variation in treatment of primary biliary cirrhosis and effect on clinical outcomes.
    Talwalkar JA; Gossard AA
    Hepatology; 2008 Apr; 47(4):1428. PubMed ID: 18366110
    [No Abstract]   [Full Text] [Related]  

  • 22. A case of Alagille syndrome presenting with chronic cholestasis in an adult.
    Kim J; Yang B; Paik N; Choe YH; Paik YH
    Clin Mol Hepatol; 2017 Sep; 23(3):260-264. PubMed ID: 28683534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alström syndrome with liver cirrhosis: first case from Turkey.
    Bıyık M; Uçar R; Güngör G; Çakır ÖÖ; Esen H; Aksan S; Ataseven H; Demir A
    Turk J Gastroenterol; 2013; 24(6):546-8. PubMed ID: 24623295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol.
    Kaplan MM; Poupon R
    Hepatology; 2009 Aug; 50(2):652. PubMed ID: 19309721
    [No Abstract]   [Full Text] [Related]  

  • 26. Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy.
    Zukowski TH; Jorgensen RA; Dickson ER; Lindor KD
    Am J Gastroenterol; 1998 Jun; 93(6):958-61. PubMed ID: 9647028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients and patience: the pitfalls of primary biliary cirrhosis trials.
    Mayo MJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):552-3. PubMed ID: 16327817
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of ursodeoxycholic acid in children with prolonged hepatitis A virus infection that may be a trigger factor for autoimmune hepatitis.
    Koçak N; Saltik IN
    Am J Gastroenterol; 2001 Feb; 96(2):610-1. PubMed ID: 11232728
    [No Abstract]   [Full Text] [Related]  

  • 29. Methotrexate for treatment of primary biliary cirrhosis.
    Bonis PA; Kaplan M
    Hepatology; 2006 Mar; 43(3):632; author reply 632-3. PubMed ID: 16496314
    [No Abstract]   [Full Text] [Related]  

  • 30. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
    Stiehl A
    Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
    Walker LJ; Newton J; Jones DE; Bassendine MF
    Hepatology; 2009 Jan; 49(1):337-8; author reply 338. PubMed ID: 19035342
    [No Abstract]   [Full Text] [Related]  

  • 32. Ursodeoxycholic acid in primary biliary cirrhosis.
    Combes B
    Semin Liver Dis; 1997 May; 17(2):125-8. PubMed ID: 9170199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does prophylactic ursodeoxycholic acid treatment of liver transplant patients prevent acute rejection?
    Keiding S
    Hepatology; 1998 Jun; 27(6):1748-9. PubMed ID: 9620354
    [No Abstract]   [Full Text] [Related]  

  • 34. How, why, and when does primary biliary cirrhosis recur after liver transplantation?
    Williams R; Gershwin ME
    Liver Transpl; 2007 Sep; 13(9):1214-6. PubMed ID: 17763403
    [No Abstract]   [Full Text] [Related]  

  • 35. Ursodeoxycholic acid in the treatment of AIDS-associated cholangiopathy.
    Castiella A; Iribarren JA; López P; Arrizabalaga J; Rodríguez F; von Wichmann MA; Arenas JI
    Am J Med; 1997 Aug; 103(2):170-1. PubMed ID: 9274905
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hematemesis in cirrhotic patients: diagnostic-therapeutic progress and new criteria for assessing the surgical risk].
    Castiglioni GC; Castagneto M; Sganga G; Giovannini I
    Chir Patol Sper; 1986; 34(1-2):3-14. PubMed ID: 3268397
    [No Abstract]   [Full Text] [Related]  

  • 37. [Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid].
    Mörk H; al-Taie O; Klinge O; Scheurlen M
    Z Gastroenterol; 1997 Dec; 35(12):1087-91. PubMed ID: 9487641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-hepatic manifestations of the overlap syndrome (a case report)].
    Mikheeva OM; Il'chenko LIu
    Eksp Klin Gastroenterol; 2006; (6):116-25. PubMed ID: 17612105
    [No Abstract]   [Full Text] [Related]  

  • 39. Ursodeoxycholic acid as a supplementary treatment in corrected biliary atresia.
    Smaropoulos EC; Kaselas B
    Eur J Pediatr Surg; 2006 Apr; 16(2):138-9. PubMed ID: 16685625
    [No Abstract]   [Full Text] [Related]  

  • 40. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
    Luketic VA; Sanyal AJ
    Gastroenterologist; 1994 Mar; 2(1):74-9. PubMed ID: 8055235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.